Combination of antisense oligonucleotide therapy with BIO101 demonstrates synergistic beneficial effects in severe SMA-like mice - Université d'Évry Access content directly
Conference Papers Year : 2022

Combination of antisense oligonucleotide therapy with BIO101 demonstrates synergistic beneficial effects in severe SMA-like mice

Cynthia Bezier
  • Function : Author
Parvin Nazari Hashemi
  • Function : Contributor
Steve Cottin
René Lafont
Stanislas Veillet
  • Function : Contributor
  • PersonId : 1098130
Frédéric Charbonnier
  • Function : Contributor
Pierre Dilda
Mathilde Latil
  • Function : relator_co_last_author
No file

Dates and versions

hal-04496200 , version 1 (08-03-2024)

Licence

Attribution

Identifiers

  • HAL Id : hal-04496200 , version 1

Cite

Cynthia Bezier, Parvin Nazari Hashemi, Steve Cottin, René Lafont, Stanislas Veillet, et al.. Combination of antisense oligonucleotide therapy with BIO101 demonstrates synergistic beneficial effects in severe SMA-like mice. 3èmes International Scientific Congress on SMA, SMA Europe, Oct 2022, Barcelone (ES), Spain. ⟨hal-04496200⟩
2 View
0 Download

Share

Gmail Facebook X LinkedIn More